Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 2,602.50
-13.25 (-0.51%)
At close: Aug 8, 2025
Ajanta Pharma Employees
Ajanta Pharma had 9,628 employees as of March 31, 2025. The number of employees increased by 1,555 or 19.26% compared to the previous year.
Employees
9,628
Change (1Y)
1,555
Growth (1Y)
19.26%
Revenue / Employee
4.99M INR
Profits / Employee
965.89K INR
Market Cap
325.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 9,628 | 1,555 | 19.26% |
| Mar 31, 2024 | 8,073 | 360 | 4.67% |
| Mar 31, 2023 | 7,713 | 479 | 6.62% |
| Mar 31, 2022 | 7,234 | 199 | 2.83% |
| Mar 31, 2021 | 7,035 | -132 | -1.84% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 403,303 |
| HDFC Bank | 214,521 |
| Bharti Airtel | 13,593 |
| Tata Consultancy Services | 607,979 |
| ICICI Bank | 182,665 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Hindustan Unilever | 18,802 |
Ajanta Pharma News
- 9 days ago - Top stocks to buy today: Stock recommendations for July 31, 2025 - check list - The Times of India
- 3 months ago - Ajanta Pharma Q4 Results: Net profit grows 11% YoY to Rs 225 crore, EBITDA Margin at 25% - Business Upturn
- 4 months ago - Stocks to buy today on brokerages’ call: IndiGo, Ajanta Pharma, TBO, HDFC Bank, Vodafone Idea among top picks – Check investment target - Business Upturn
- 4 months ago - Jefferies initiates Buy on Ajanta Pharma, sees 11% upside due to strong presence in branded generics markets - Business Upturn
- 4 months ago - Stocks to watch today: Interglobe Aviation, Ajanta Pharma, HDFC Bank, Vodafone Idea, Hindalco, TBO, L&T in focus on brokerage reports - Business Upturn
- 6 months ago - Ajanta Pharma Q3FY25 results: Revenue rises 4% YoY to Rs 1,146 crore, PAT Up 11% to Rs 233 crore - Business Upturn
- 8 months ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 10 months ago - Ajanta Pharma declares first interim dividend of ₹28 per share for FY25 - Business Upturn